Corti, P <br/><br/>
Rituximab for immune hemolytic anemia following T- and B-Cell-depleted hematopoietic stem cell transplantation.  [electronic resource] 

 -  Acta haematologica  2003 
 - 43-5 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>0001-5792 
<br/><br/><label>Standard No.: </label>10.1159/000067271  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anemia, Hemolytic, Autoimmune--drug therapy<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antigens, CD19--blood<br/>B-Lymphocytes--cytology<br/>Female<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Hemoglobins--metabolism<br/>Humans<br/>Infant<br/>Lymphocyte Depletion--adverse effects<br/>Mucopolysaccharidosis I--complications<br/>Rituximab<br/>T-Lymphocytes<br/>Transplantation Chimera<br/>Transplantation, Homologous--adverse effects<br/>Treatment Outcome